These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27897199)

  • 41. Terconazole - a new broad-spectrum antifungal.
    Van Cutsem J; Van Gerven F; Zaman R; Janssen PA
    Chemotherapy; 1983; 29(5):322-31. PubMed ID: 6617296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the antimicrobial, antioxidant, and anti-inflammatory activities of hydroxychavicol for its potential use as an oral care agent.
    Sharma S; Khan IA; Ali I; Ali F; Kumar M; Kumar A; Johri RK; Abdullah ST; Bani S; Pandey A; Suri KA; Gupta BD; Satti NK; Dutt P; Qazi GN
    Antimicrob Agents Chemother; 2009 Jan; 53(1):216-22. PubMed ID: 18573934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pyocyanin as anti-tyrosinase and anti tinea corporis: A novel treatment study.
    El-Zawawy NA; Ali SS
    Microb Pathog; 2016 Nov; 100():213-220. PubMed ID: 27671284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemotherapeutic evaluation of clotrimazole (Bay b 5097, 1 (o-chloro- - -diphenylbenzyl) imidazole).
    Waitz JA; Moss EL; Weinstein MJ
    Appl Microbiol; 1971 Nov; 22(5):891-8. PubMed ID: 4943591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The advantages of topical combination therapy in the treatment of inflammatory dermatomycoses.
    Havlickova B; Friedrich M
    Mycoses; 2008 Sep; 51 Suppl 4():16-26. PubMed ID: 18783560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro susceptibility testing of amorolfine in pathogenic fungi isolated from dermatomycosis patients in China.
    Li RY; Wan Z; Wang AP; Shen YN; Lu CM; Li M; Xi LY; Liu WD; Zeng FQ
    Mycoses; 2004 Oct; 47(9-10):402-6. PubMed ID: 15504124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antifungal activity, mode of action and anti-biofilm effects of Laurus nobilis Linnaeus essential oil against Candida spp.
    Peixoto LR; Rosalen PL; Ferreira GL; Freires IA; de Carvalho FG; Castellano LR; de Castro RD
    Arch Oral Biol; 2017 Jan; 73():179-185. PubMed ID: 27771586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trichophyton species of Arthroderma benhamiae - a new infectious agent in dermatology.
    Nenoff P; Uhrlaß S; Krüger C; Erhard M; Hipler UC; Seyfarth F; Herrmann J; Wetzig T; Schroedl W; Gräser Y
    J Dtsch Dermatol Ges; 2014 Jul; 12(7):571-81. PubMed ID: 24981469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro and in vivo antidermatophytic activity of saperconazole, a new fluorinated triazole.
    Fu KP; Isaacson DM; Lococo J; Foleno B; Hilliard J
    Drugs Exp Clin Res; 1992; 18(11-12):443-6. PubMed ID: 1308468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of the growth in vitro of Trichophyton mentagrophytes, Trichophyton erinacei and Microsporum persicolor by miconazole and chlorhexidine.
    Perrins N; Howell SA; Moore M; Bond R
    Vet Dermatol; 2005 Oct; 16(5):330-3. PubMed ID: 16238813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of oral antifungal agents for the treatment of superficial fungal infections in immunocompromised patients.
    Millikan LE
    Cutis; 2001 Jul; 68(1 Suppl):6-14. PubMed ID: 11499333
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preclinical data and mode of action of amorolfine.
    Polak A
    Dermatology; 1992; 184 Suppl 1():3-7. PubMed ID: 1550968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Topical and systemic antifungals in dermatology practice.
    Durdu M; Ilkit M; Tamadon Y; Tolooe A; Rafati H; Seyedmousavi S
    Expert Rev Clin Pharmacol; 2017 Feb; 10(2):225-237. PubMed ID: 27868472
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro activity of eugenol against Candida albicans biofilms.
    He M; Du M; Fan M; Bian Z
    Mycopathologia; 2007 Mar; 163(3):137-43. PubMed ID: 17356790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inactivation of dermatophyte infection by nonthermal plasma on animal model.
    Scholtz V; Soušková H; Švarcová M; Kríha V; Živná H; Julák J
    Med Mycol; 2017 Jun; 55(4):422-428. PubMed ID: 28339534
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Parmelia cirrhatum: a potential source of broad spectrum natural antifungal.
    Shahi SK; Patra M; Dikshit A; Upreti DK
    Phytother Res; 2003 Apr; 17(4):399-400. PubMed ID: 12722148
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antifungal activities of Astragalus verus Olivier. against Trichophyton verrucosum on in vitro and in vivo guinea pig model of dermatophytosis.
    Mikaeili A; Modaresi M; Karimi I; Ghavimi H; Fathi M; Jalilian N
    Mycoses; 2012 Jul; 55(4):318-25. PubMed ID: 21838718
    [TBL] [Abstract][Full Text] [Related]  

  • 58. VT-1161 dosed once daily or once weekly exhibits potent efficacy in treatment of dermatophytosis in a guinea pig model.
    Garvey EP; Hoekstra WJ; Moore WR; Schotzinger RJ; Long L; Ghannoum MA
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1992-7. PubMed ID: 25605358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the therapeutic efficacy of oral doses of fluconazole and griseofulvin in a guinea pig model of dermatophytosis.
    Nagino K; Shimohira H; Ogawa M; Uchida K; Yamaguchi H
    J Antibiot (Tokyo); 2000 Feb; 53(2):207-10. PubMed ID: 10805585
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparative in vitro and in vivo effect of lactones and arnebins on Trichophyton mentagrophytes and Candida albicans.
    Wahab S; Tandon RN; Jacob Z; Chandra B; Srivastava OP
    Indian J Med Res; 1982 Dec; 76 Suppl():77-82. PubMed ID: 6764457
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.